In earnings for the third quarter of 2025, the firm provided updated guidance, noting that for 2025, total revenue was now expected to be $510 million, up from prior guidance of more than $500 million ...
Many RhD-negative pregnant women lose detectable anti-D protection before delivery, which may leave a small window of risk for HDFN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback